Neural basis for improgan antinociception

Mary Heinricher, M. E. Martenson, J. W. Nalwalk, L. B. Hough

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Improgan, the prototype compound of a novel class of non-opioid analgesic drugs derived from histamine antagonists, attenuates thermal and mechanical nociception in rodents following intracerebroventricular (i.c.v.) administration. Improgan does not bind to known opioid, histamine or cannabinoid receptors, and its molecular target has not been identified. It is known however, that improgan acts directly in the periaqueductal gray and the rostral ventromedial medulla to produce its antinociceptive effects, and that inactivation of the rostral ventromedial medulla prevents the antinociceptive effect of improgan given i.c.v. Here we used in vivo single-cell recording in lightly anesthetized rats to show that improgan engages pain-modulating neurons in the medulla to produce antinociception. Following improgan administration, OFF-cells, which inhibit nociception, became continuously active and no longer paused during noxious stimulation. The increase in OFF-cell firing does not represent a non-specific neuroexcitant effect of this drug, since ON-cell discharge, associated with net nociceptive facilitation, was depressed. NEUTRAL-cell firing was unaffected by improgan. The net response of rostral ventromedial medulla (RVM) neurons to improgan is thus comparable to that evoked by μ-opioids and cannabinoids, well known RVM-active analgesic drugs. This common basis for improgan, opioid, and cannabinoid antinociception in the RVM supports the idea that improgan functions as a specific analgesic agent.

Original languageEnglish (US)
Pages (from-to)1414-1420
Number of pages7
JournalNeuroscience
Volume169
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Analgesics
Nociception
Cannabinoids
Opioid Analgesics
SKF 92374
Neurons
Histamine Receptors
Cannabinoid Receptors
Periaqueductal Gray
Histamine Antagonists
Opioid Receptors
Rodentia
Hot Temperature
Pain
Pharmaceutical Preparations

Keywords

  • Brainstem
  • OFF-cells
  • ON-cells
  • Pain-modulation
  • Rostral ventromedial medulla

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Heinricher, M., Martenson, M. E., Nalwalk, J. W., & Hough, L. B. (2010). Neural basis for improgan antinociception. Neuroscience, 169(3), 1414-1420. https://doi.org/10.1016/j.neuroscience.2010.05.042

Neural basis for improgan antinociception. / Heinricher, Mary; Martenson, M. E.; Nalwalk, J. W.; Hough, L. B.

In: Neuroscience, Vol. 169, No. 3, 09.2010, p. 1414-1420.

Research output: Contribution to journalArticle

Heinricher, M, Martenson, ME, Nalwalk, JW & Hough, LB 2010, 'Neural basis for improgan antinociception', Neuroscience, vol. 169, no. 3, pp. 1414-1420. https://doi.org/10.1016/j.neuroscience.2010.05.042
Heinricher, Mary ; Martenson, M. E. ; Nalwalk, J. W. ; Hough, L. B. / Neural basis for improgan antinociception. In: Neuroscience. 2010 ; Vol. 169, No. 3. pp. 1414-1420.
@article{0a00d9d807aa4411b1057a36221cda43,
title = "Neural basis for improgan antinociception",
abstract = "Improgan, the prototype compound of a novel class of non-opioid analgesic drugs derived from histamine antagonists, attenuates thermal and mechanical nociception in rodents following intracerebroventricular (i.c.v.) administration. Improgan does not bind to known opioid, histamine or cannabinoid receptors, and its molecular target has not been identified. It is known however, that improgan acts directly in the periaqueductal gray and the rostral ventromedial medulla to produce its antinociceptive effects, and that inactivation of the rostral ventromedial medulla prevents the antinociceptive effect of improgan given i.c.v. Here we used in vivo single-cell recording in lightly anesthetized rats to show that improgan engages pain-modulating neurons in the medulla to produce antinociception. Following improgan administration, OFF-cells, which inhibit nociception, became continuously active and no longer paused during noxious stimulation. The increase in OFF-cell firing does not represent a non-specific neuroexcitant effect of this drug, since ON-cell discharge, associated with net nociceptive facilitation, was depressed. NEUTRAL-cell firing was unaffected by improgan. The net response of rostral ventromedial medulla (RVM) neurons to improgan is thus comparable to that evoked by μ-opioids and cannabinoids, well known RVM-active analgesic drugs. This common basis for improgan, opioid, and cannabinoid antinociception in the RVM supports the idea that improgan functions as a specific analgesic agent.",
keywords = "Brainstem, OFF-cells, ON-cells, Pain-modulation, Rostral ventromedial medulla",
author = "Mary Heinricher and Martenson, {M. E.} and Nalwalk, {J. W.} and Hough, {L. B.}",
year = "2010",
month = "9",
doi = "10.1016/j.neuroscience.2010.05.042",
language = "English (US)",
volume = "169",
pages = "1414--1420",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Neural basis for improgan antinociception

AU - Heinricher, Mary

AU - Martenson, M. E.

AU - Nalwalk, J. W.

AU - Hough, L. B.

PY - 2010/9

Y1 - 2010/9

N2 - Improgan, the prototype compound of a novel class of non-opioid analgesic drugs derived from histamine antagonists, attenuates thermal and mechanical nociception in rodents following intracerebroventricular (i.c.v.) administration. Improgan does not bind to known opioid, histamine or cannabinoid receptors, and its molecular target has not been identified. It is known however, that improgan acts directly in the periaqueductal gray and the rostral ventromedial medulla to produce its antinociceptive effects, and that inactivation of the rostral ventromedial medulla prevents the antinociceptive effect of improgan given i.c.v. Here we used in vivo single-cell recording in lightly anesthetized rats to show that improgan engages pain-modulating neurons in the medulla to produce antinociception. Following improgan administration, OFF-cells, which inhibit nociception, became continuously active and no longer paused during noxious stimulation. The increase in OFF-cell firing does not represent a non-specific neuroexcitant effect of this drug, since ON-cell discharge, associated with net nociceptive facilitation, was depressed. NEUTRAL-cell firing was unaffected by improgan. The net response of rostral ventromedial medulla (RVM) neurons to improgan is thus comparable to that evoked by μ-opioids and cannabinoids, well known RVM-active analgesic drugs. This common basis for improgan, opioid, and cannabinoid antinociception in the RVM supports the idea that improgan functions as a specific analgesic agent.

AB - Improgan, the prototype compound of a novel class of non-opioid analgesic drugs derived from histamine antagonists, attenuates thermal and mechanical nociception in rodents following intracerebroventricular (i.c.v.) administration. Improgan does not bind to known opioid, histamine or cannabinoid receptors, and its molecular target has not been identified. It is known however, that improgan acts directly in the periaqueductal gray and the rostral ventromedial medulla to produce its antinociceptive effects, and that inactivation of the rostral ventromedial medulla prevents the antinociceptive effect of improgan given i.c.v. Here we used in vivo single-cell recording in lightly anesthetized rats to show that improgan engages pain-modulating neurons in the medulla to produce antinociception. Following improgan administration, OFF-cells, which inhibit nociception, became continuously active and no longer paused during noxious stimulation. The increase in OFF-cell firing does not represent a non-specific neuroexcitant effect of this drug, since ON-cell discharge, associated with net nociceptive facilitation, was depressed. NEUTRAL-cell firing was unaffected by improgan. The net response of rostral ventromedial medulla (RVM) neurons to improgan is thus comparable to that evoked by μ-opioids and cannabinoids, well known RVM-active analgesic drugs. This common basis for improgan, opioid, and cannabinoid antinociception in the RVM supports the idea that improgan functions as a specific analgesic agent.

KW - Brainstem

KW - OFF-cells

KW - ON-cells

KW - Pain-modulation

KW - Rostral ventromedial medulla

UR - http://www.scopus.com/inward/record.url?scp=77955281760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955281760&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2010.05.042

DO - 10.1016/j.neuroscience.2010.05.042

M3 - Article

C2 - 20570607

AN - SCOPUS:77955281760

VL - 169

SP - 1414

EP - 1420

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -